Last update 22 Mar 2025

[18F]THK-5351

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
FluoroTau, 3H-THK5351, F-18 THK-5351
+ [4]
Target
Action
inhibitors
Mechanism
TAU inhibitors(Microtubule-associated protein tau inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H18FN3O2
InChIKeyDLVXFZWSPCOWSN-DHZJDKHOSA-N
CAS Registry1707148-68-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cognitive DysfunctionPhase 2
Taiwan Province
01 Nov 2020
NeuroinflammationPhase 2
Taiwan Province
01 Nov 2020
Depressive Disorder, MajorPhase 2
Taiwan Province
23 Mar 2018
Parkinson DiseasePhase 2
Taiwan Province
31 Jul 2017
Supranuclear Palsy, ProgressivePhase 2
Taiwan Province
31 Jul 2017
Alzheimer DiseasePhase 2
United States
11 Jan 2016
DementiaPhase 2
Taiwan Province
04 Jan 2016
Mild cognitive disorderPhase 2
Taiwan Province
04 Jan 2016
Plaque, AmyloidPhase 2
Taiwan Province
04 Jan 2016
StrokePhase 2
Taiwan Province
04 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
uoqoaucrle(gjuzsgoufp) = muvazwzpmp ysulhxeuyn (tbwbyasxxu, 11.6)
-
18 Sep 2019
Phase 2
17
Lumbar Puncture (optional)+18F-THK-5351
(Cognitive Impairment)
hfsknlbbgi(tevlktyhno) = ecaakjmyzj svkgifndyf (ylowcznziw, ymiheibfjf - snqltdgmjm)
-
19 Nov 2018
Lumbar Puncture (optional)+18F-THK-5351
(No Cognitive Impairment)
hfsknlbbgi(tevlktyhno) = rrjbdgqqbs svkgifndyf (ylowcznziw, fpwytvdmni - zrwotpfbpr)
Not Applicable
-
-
THK5351 and its derivatives
ntnpcmpyak(lzrqzrcjfs) = zyhaafjqtx rnavhpesqd (cogmmyjrkr )
-
01 Jul 2018
Phase 1
-
12
owknuldqtd(fwrawfrvor) = cwskfxbqzs rfheykafuv (duiadzpgar )
-
01 Sep 2017
Not Applicable
-
-
ucztffapih(dtchebuzsb) = hjnazpegnw avvyyfdwki (vizcjzxogi )
-
01 Jul 2017
Not Applicable
-
(Normal controls (NC))
ehquxjwwny(jclxfwvclo) = nfqkakukse xjprdptwrz (ewbqoobftz )
-
01 Jul 2017
(Mild cognitive impairment (MCI))
ehquxjwwny(jclxfwvclo) = fvosgaxwql xjprdptwrz (ewbqoobftz )
Not Applicable
-
7
mvdojhdlfu(qgicwfbqcj) = rxaczyokqx kaciednhnl (mdeqaxebnu )
-
01 Jul 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free